Meta-analysis on inoperable pancreatic cancer: A comparison between gemcitabine-based combination therapy and gemcitabine alone

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

373

HTML

2762

Figures (1-7)

499

Tables (1-3)

204

Sum=3838

Nov 21, 2006 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Nov 21, 2006; 12(43): 6973-6981
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6973

Full Size Figure Download Figure

Figure 2 Fixed effect model on RD of 6-mo survival rate.

Citation: Xie DR, Liang HL, Wang Y, Guo SS, Yang Q. Meta-analysis on inoperable pancreatic cancer: A comparison between gemcitabine-based combination therapy and gemcitabine alone. World J Gastroenterol 2006; 12(43): 6973-6981
URL: https://www.wjgnet.com/1007-9327/full/v12/i43/6973.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i43.6973